1. Home
  2. LGVN vs RETO Comparison

LGVN vs RETO Comparison

Compare LGVN & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • RETO
  • Stock Information
  • Founded
  • LGVN 2014
  • RETO 1999
  • Country
  • LGVN United States
  • RETO China
  • Employees
  • LGVN N/A
  • RETO N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • RETO Multi-Sector Companies
  • Sector
  • LGVN Health Care
  • RETO Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • RETO Nasdaq
  • Market Cap
  • LGVN 23.4M
  • RETO 24.7M
  • IPO Year
  • LGVN 2021
  • RETO 2017
  • Fundamental
  • Price
  • LGVN $1.31
  • RETO $2.41
  • Analyst Decision
  • LGVN Strong Buy
  • RETO
  • Analyst Count
  • LGVN 3
  • RETO 0
  • Target Price
  • LGVN $8.67
  • RETO N/A
  • AVG Volume (30 Days)
  • LGVN 134.8K
  • RETO 103.7K
  • Earning Date
  • LGVN 08-13-2025
  • RETO 07-15-2025
  • Dividend Yield
  • LGVN N/A
  • RETO N/A
  • EPS Growth
  • LGVN N/A
  • RETO N/A
  • EPS
  • LGVN N/A
  • RETO N/A
  • Revenue
  • LGVN $2,225,000.00
  • RETO $1,828,976.00
  • Revenue This Year
  • LGVN N/A
  • RETO N/A
  • Revenue Next Year
  • LGVN $51.48
  • RETO N/A
  • P/E Ratio
  • LGVN N/A
  • RETO N/A
  • Revenue Growth
  • LGVN 127.50
  • RETO N/A
  • 52 Week Low
  • LGVN $1.14
  • RETO $1.85
  • 52 Week High
  • LGVN $6.40
  • RETO $18.20
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 51.52
  • RETO 33.16
  • Support Level
  • LGVN $1.27
  • RETO $1.91
  • Resistance Level
  • LGVN $1.40
  • RETO $3.15
  • Average True Range (ATR)
  • LGVN 0.09
  • RETO 0.27
  • MACD
  • LGVN 0.01
  • RETO -0.11
  • Stochastic Oscillator
  • LGVN 50.00
  • RETO 23.71

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: